Skip to Content

Novozymes A/S ADR NVZMY

Morningstar Rating
$56.45 +0.21 (0.37%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NVZMY is trading at a 4% premium.
Price
$56.36
Fair Value
$66.74
Uncertainty
Medium
1-Star Price
$21.84
5-Star Price
$32.93
Economic Moat
Mlt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NVZMY is a good fit for your portfolio.

Trading Information

Previous Close Price
$56.24
Day Range
$56.2556.99
52-Week Range
$38.7556.99
Bid/Ask
$56.10 / $56.78
Market Cap
$26.21 Bil
Volume/Avg
291,544 / 18,499

Key Statistics

Price/Earnings (Normalized)
29.05
Price/Sales
5.64
Dividend Yield (Trailing)
2.56%
Dividend Yield (Forward)
2.10%
Total Yield
2.56%

Company Profile

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company is the world leader in industrial enzymes and microbial solutions, with a near-50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, working across more than 30 research and development and application centers and 23 manufacturing sites.
Sector
Basic Materials
Industry
Specialty Chemicals
Stock Style Box
Large Growth
Total Number of Employees
6,756

Competitors

Valuation

Metric
NVZMY
IFF
DSFIR
Price/Earnings (Normalized)
29.0525.78
Price/Book Value
7.041.191.07
Price/Sales
5.641.74
Price/Cash Flow
23.3716.83
Price/Earnings
NVZMY
IFF
DSFIR

Financial Strength

Metric
NVZMY
IFF
DSFIR
Quick Ratio
0.760.771.35
Current Ratio
1.301.742.15
Interest Coverage
23.081.273.81
Quick Ratio
NVZMY
IFF
DSFIR

Profitability

Metric
NVZMY
IFF
DSFIR
Return on Assets (Normalized)
11.42%1.01%
Return on Equity (Normalized)
23.56%2.01%
Return on Invested Capital (Normalized)
22.72%2.41%
Return on Assets
NVZMY
IFF
DSFIR
See how this stock stacks up to its competitors with Morningstar Investor

Specialty Chemicals Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LIN
Linde PLCFybfyz$215.7 Bil
SHW
Sherwin-Williams CoJwlq$82.1 Bil
ECL
Ecolab IncJnfyc$62.9 Bil
APD
Air Products & Chemicals IncPqchj$51.0 Bil
PPG
PPG Industries IncFjbwzx$33.5 Bil
LYB
LyondellBasell Industries NV Class AHdrdc$32.1 Bil
DD
DuPont de Nemours IncYtvpsw$29.2 Bil
IFF
International Flavors & Fragrances IncSly$19.8 Bil
ALB
Albemarle CorpSqyxsc$14.3 Bil
SQM
Sociedad Quimica Y Minera De Chile SA ADRHvckzp$12.2 Bil

Sponsor Center